Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
BDP9066 CAS No.2226507-04-4
BDP9066 CAS No.2226507-04-4
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-2984 | 10mg | 240.00 | + Add to cart |
|
| R-R-2984 | 25mg | 500.00 | + Add to cart |
|
|
|
||||
Product description
BDP9066/CAS No.2226507-04-4 is a potent and selective myotonic dystrophy-related Cdc42-binding kinase MRCK inhibitor with an IC50 of 64 nM for MRCKβ in SCC12 cells, Ki values of 0.0136 nM and 0.0233 nM for MRCKα/β in house determinations, respectively. BDP9066 has therapeutic effect on skin cancer by reducing substrate phosphorylation.
| Appearance | N/A |
|---|---|
| Molecular Weight | 348.00 |
| Purity | >90% |
| CAS | 2226507-04-4 |
| Formula | C20H24N6 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds of BDP9066 CAS No.2226507-04-4 Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
